MedPath

Micafungin

These highlights do not include all the information needed to use MICAFUNGIN FOR INJECTION safely and effectively. See full prescribing information for MICAFUNGIN FOR INJECTION. MICAFUNGIN for injection, for intravenous useInitial U.S. Approval: 2005

Approved
Approval ID

f8198836-4011-40b9-af25-466ae08727f8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2020

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Micafungin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-729
Application NumberANDA207344
Product Classification
M
Marketing Category
C73584
G
Generic Name
Micafungin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 30, 2020
FDA Product Classification

INGREDIENTS (4)

Lactose MonohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
Micafungin SodiumActive
Quantity: 100 mg in 1 1
Code: IS1UP79R56
Classification: ACTIB
Anhydrous Citric AcidInactive
Code: XF417D3PSL
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.